Inflammatory mediators in heart failure (Q33862362)

29 July 2017

1 reference

title

Inflammatory mediators in heart failure (English)

1 reference

29 July 2017

1 reference

Niebauer J

1

1 reference

29 July 2017

publication date

1 February 2000

1 reference

International Journal of Cardiology

29 July 2017

published in

1 reference

29 July 2017

volume

72

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

209-213

1 reference

Basic mechanisms in heart failure: the cytokine hypothesis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Formation of ion-permeable channels by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

The role of cytokines in disease progression in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Wasting as independent risk factor for mortality in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Increased circulating cytokines in patients with myocarditis and cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Expression and Functional Significance of Tumor Necrosis Factor Receptors in Human Myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Systemic inflammation in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

The cardiovascular response of normal humans to the administration of endotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

TNF-induced cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Three year mortality in heart failure patients with very low left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Elevated soluble CD14 receptors and altered cytokines in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Pro-inflammatory cytokines and endothelium-dependent vasodilation in the forearm. Serial assessment in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-alpha in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900190-4

7 January 2021

10.1016/S0167-5273(99)00190-4

Identifiers

DOI

1 reference

29 July 2017

1 reference